{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:12:59Z","timestamp":1787688779177,"version":"build-2784847793"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1053\/j.ajkd.2016.05.024","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T06:34:04Z","timestamp":1476945244000},"page":"S24-S32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"S1","title":["Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use"],"prefix":"10.1053","volume":"68","author":[{"given":"Michael","family":"Copland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Komenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Weinhandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Morfin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.ajkd.2016.05.024_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.ackd.2006.10.005","article-title":"Chronic kidney disease-mineral-bone disorder: a new paradigm","volume":"14","author":"Moe","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"issue":"9","key":"10.1053\/j.ajkd.2016.05.024_bib2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/SMJ.0b013e318261f7fe","article-title":"Current concepts and management strategies in chronic kidney disease-mineral and bone disorder","volume":"105","author":"Chauhan","year":"2012","journal-title":"South Med J"},{"issue":"12","key":"10.1053\/j.ajkd.2016.05.024_bib3","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.2215\/CJN.04260413","article-title":"CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis","volume":"8","author":"Block","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2016.05.024_bib4","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Guti\u00e9rrez","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"3 suppl 1","key":"10.1053\/j.ajkd.2016.05.024_bib5","first-page":"S1","article-title":"US Renal Data System 2015 Annual Data Report: epidemiology of kidney disease in the United States","volume":"67","author":"Saran","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2016.05.024_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/ckj\/sfs173","article-title":"Management of hyperphosphataemia in chronic kidney disease-challenges and solutions","volume":"6","author":"Ketteler","year":"2013","journal-title":"Clin Kidney J"},{"issue":"1","key":"10.1053\/j.ajkd.2016.05.024_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/hdi.12315","article-title":"Phosphate binder pill burden, patient-reported non-adherence, and mineral bone disorder markers: findings from the DOPPS","volume":"20","author":"Fissell","year":"2016","journal-title":"Hemodial Int"},{"issue":"4","key":"10.1053\/j.ajkd.2016.05.024_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/j.ajkd.2009.06.004","article-title":"Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials","volume":"54","author":"Navaneethan","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2016.05.024_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13643-015-0177-1","article-title":"Cinacalcet versus standard treatment for chronic kidney disease: a protocol for a systematic review and meta-analysis","volume":"5","author":"Sekercioglu","year":"2016","journal-title":"Syst Rev"},{"key":"10.1053\/j.ajkd.2016.05.024_bib10","unstructured":"Arbor Research Collaborative for Health. The DOPPS Practice Monitor. http:\/\/www.dopps.org\/DPM\/. Accessed May 20,\u00a02015."},{"issue":"3","key":"10.1053\/j.ajkd.2016.05.024_bib11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2016.05.024_bib12","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ajkd.2016.05.024_bib13","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1093\/ndt\/gfl257","article-title":"Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients","volume":"21","author":"Noordzij","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1053\/j.ajkd.2016.05.024_bib14","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2016.05.024_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/0886022X.2012.741426","article-title":"Calciphylaxis: a report of six cases and review of literature","volume":"35","author":"Yalin","year":"2013","journal-title":"Ren Fail"},{"issue":"2","key":"10.1053\/j.ajkd.2016.05.024_bib16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.ajkd.2010.03.022","article-title":"Dietary potassium intake and mortality in long-term hemodialysis patients","volume":"56","author":"Noori","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2016.05.024_bib17","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1111\/j.1523-1755.2004.09005.x","article-title":"A\u00a0comparison of clinically useful phosphorus binders for patients with chronic kidney failure","volume":"90","author":"Emmett","year":"2004","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"10.1053\/j.ajkd.2016.05.024_bib18","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/ki.2015.67","article-title":"A\u00a0dearth of data: the problem of phosphorus in prescription medications","volume":"87","author":"Sherman","year":"2015","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2016.05.024_bib19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0272-6386(12)80882-1","article-title":"Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate","volume":"18","author":"Hou","year":"1991","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2016.05.024_bib20","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.2215\/CJN.09761110","article-title":"Prevalence and demographic and clinical associations of health literacy in patients on maintenance hemodialysis","volume":"6","author":"Green","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1 suppl 1","key":"10.1053\/j.ajkd.2016.05.024_bib21","first-page":"Svii","article-title":"US Renal Data System 2014 Annual Data Report: epidemiology of kidney disease in the United States","volume":"66","author":"Saran","year":"2015","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"3","key":"10.1053\/j.ajkd.2016.05.024_bib22","first-page":"A76","article-title":"The role of race and poverty in access to foods that enable individuals to adhere to dietary guidelines","volume":"3","author":"Baker","year":"2006","journal-title":"Prev Chronic Dis"},{"issue":"11","key":"10.1053\/j.ajkd.2016.05.024_bib23","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1681\/ASN.2010020221","article-title":"Low socioeconomic status associates with higher serum phosphate irrespective\u00a0of race","volume":"21","author":"Guti\u00e9rrez","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2016.05.024_bib24","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1093\/ndt\/gfl289","article-title":"Phosphate binders and management of hyperphosphataemia in end-stage renal disease","volume":"21","author":"Savica","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2016.05.024_bib25","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1046\/j.1523-1755.62.s82.15.x","article-title":"Cardiovascular calcification in patients with end-stage renal disease: a century-old phenomenon","volume":"82","author":"Qunibi","year":"2002","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"10.1053\/j.ajkd.2016.05.024_bib26","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","volume":"68","author":"Block","year":"2005","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2016.05.024_bib27","first-page":"381","article-title":"Simultaneous lowering of serum phosphate and LDL-cholesterol by sevelamer hydrochloride (RenaGel) in dialysis patients","volume":"50","author":"Wilkes","year":"1998","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2016.05.024_bib28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1053\/j.ajkd.2007.12.002","article-title":"A\u00a0comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis\u00a0of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data","volume":"51","author":"St Peter","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2016.05.024_bib29","first-page":"887","article-title":"Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate","volume":"4","author":"Mohammed","year":"2008","journal-title":"Ther Clin Risk Manag"},{"issue":"2","key":"10.1053\/j.ajkd.2016.05.024_bib30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1681\/ASN.2014020212","article-title":"Ferric citrate controls phosphorus and delivers iron in patients on dialysis","volume":"26","author":"Lewis","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2016.05.024_bib31","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/ndt\/gfv006","article-title":"Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in\u00a0dialysis patients","volume":"30","author":"Floege","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.ajkd.2016.05.024_bib32","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2215\/CJN.00290109","article-title":"Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients","volume":"4","author":"Chiu","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1 Suppl 1","key":"10.1053\/j.ajkd.2016.05.024_bib33","first-page":"e1","article-title":"2013 USRDS Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States","volume":"63","author":"Collins","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2016.05.024_bib34","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.ki.5002044","article-title":"Phosphorus balance and mineral metabolism with 3 h daily hemodialysis","volume":"71","author":"Ayus","year":"2007","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2016.05.024_bib35","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1681\/ASN.2011070688","article-title":"Effects of frequent hemodialysis on measures of CKD mineral and bone disorder","volume":"23","author":"Daugirdas","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2016.05.024_bib36","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1001\/jama.298.11.1291","article-title":"Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial","volume":"298","author":"Culleton","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"10.1053\/j.ajkd.2016.05.024_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1492-7535.2004.00076.x","article-title":"Nightly home hemodialysis: five and one-half years of experience in Lynchburg, Virginia","volume":"8","author":"Lockridge","year":"2004","journal-title":"Hemodial Int"},{"issue":"9","key":"10.1053\/j.ajkd.2016.05.024_bib38","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1681\/ASN.2005040392","article-title":"Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective,\u00a0controlled study","volume":"16","author":"Ayus","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2016.05.024_bib39","first-page":"205","article-title":"Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review","volume":"17","author":"McCullough","year":"2004","journal-title":"J\u00a0Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2016.05.024_bib40","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1046\/j.1523-1755.2002.00362.x","article-title":"Regression of left ventricular hypertrophy after conversion\u00a0to nocturnal hemodialysis","volume":"61","author":"Chan","year":"2002","journal-title":"Kidney Int"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638616302621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638616302621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:51:18Z","timestamp":1759459878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638616302621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0272638616302621"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2016.05.024","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2016.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}